Jefferies Financial Group Inc. Aurinia Pharmaceuticals Inc. Transaction History
Jefferies Financial Group Inc.
- $15.9 Billion
- Q4 2024
A detailed history of Jefferies Financial Group Inc. transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Jefferies Financial Group Inc. holds 8,587 shares of AUPH stock, worth $70,671. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,587
Previous 8,587
-0.0%
Holding current value
$70,671
Previous $77,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding AUPH
# of Institutions
227Shares Held
58.9MCall Options Held
949KPut Options Held
1.51M-
Black Rock Inc. New York, NY9.27MShares$76.3 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA8.43MShares$69.4 Million5.69% of portfolio
-
Armistice Capital, LLC New York, NY6.4MShares$52.7 Million0.81% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$32.7 Million2.55% of portfolio
-
State Street Corp Boston, MA2.92MShares$24 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $1.17B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...